Zydus Lifesciences Limited Open Interest & PCR Analysis
₹930.8Updated 21 Apr 2026, 01:26 pm IST
PCR
0.76
Bearish signal
Max Pain
₹910
Spot above by ₹21
Total CE OI
2.87M
Call writers
Total PE OI
2.18M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
Data as of 2026-04-18
Related Analysis
Frequently Asked Questions
What is Zydus Lifesciences Limited PCR (Put-Call Ratio) today?▾
Zydus Lifesciences Limited's current PCR is 0.76. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Zydus Lifesciences Limited's PCR of 0.76 indicates bearish sentiment.
What is Zydus Lifesciences Limited OI buildup type today?▾
Zydus Lifesciences Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Zydus Lifesciences Limited?▾
Zydus Lifesciences Limited has total CE (call) OI of 2871000 contracts and total PE (put) OI of 2178000 contracts for the nearest expiry. The PCR is 0.76.
How is open interest analysis useful for Zydus Lifesciences Limited trading?▾
OI analysis for Zydus Lifesciences Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Zydus Lifesciences Limited?▾
Zydus Lifesciences Limited's max pain is ₹910 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.